Charlotte Schubert
Charlotte Schubert is a GeekWire contributing writer focused on biotech, healthcare, and life sciences; she is a Seattle native with a Ph.D. in developmental biology.
Recent coverage
Front-page news, podcasts and videos about Charlotte
Seattle Hub for Synthetic Biology Secures $10M Grant to Advance DNA Recording Technology for Disease Research
The Seattle Hub for Synthetic Biology received a $10 million grant from the Washington Research Foundation to support training scientists and launching biotech startups developing DNA recording technology for studying diseases. This initiative, launched in January 2024, is a collaboration between the Allen Institute, the Chan Zuckerberg Initiative, and the University of Washington.
GeekWire Names Adaptive Biotechnologies, Blink, Helion, Impinj, and Treasury4 as 2023 Workplace of the Year Finalists
The 2023 GeekWire Awards announced five finalists for Workplace of the Year—Adaptive Biotechnologies, Blink, Helion, Impinj, and Treasury4—highlighting their employee-friendly policies amid recent challenges. Winners will be revealed on May 18 following community voting and judge evaluations.
Icosavax IPO: Seattle biotech raises $180M, stock jumps 200% on first trading day (ICVX)
Seattle biotech Icosavax surged more than 200% on its NASDAQ debut after raising over $180 million by pricing shares at $15; the company develops virus-like particle vaccines and recently began phase 1/2 trials for a COVID-19 vaccine supported by a $10 million Gates Foundation grant.
By Charlotte
See all 123University of Washington’s David Baker Credits Open-Code Rosetta Commons for Protein Design Startup Success
David Baker, director of the University of Washington’s Institute for Protein Design (IPD), emphasizes open code sharing as key to the institute’s success in creating protein design startups. The IPD’s collaborative Rosetta Commons consortium has enabled widespread development of protein design tools, fostering innovation and spinouts in biotech.
Phase Genomics Secures $2.5M to Develop AI Platform for Detecting Cancer Chromosomal Aberrations
Seattle startup Phase Genomics received $2.5 million in funding, including $2 million from the U.S. National Cancer Institute and $500,000 from Washington state's Andy Hill CARE Fund, to advance its AI-driven platform that detects chromosomal aberrations in cancer. The funding supports projects analyzing tumor samples to develop predictive scores for cancers like acute myeloid leukemia and colorectal cancer.
Seattle's Dexter Yard Develops into Major South Lake Union Biotech Cluster with Outpace Bio and Allen Institute
Seattle's Dexter Yard has become a growing biotech and life sciences hub, attracting companies like Outpace Bio and the Allen Institute with 528,000 square feet of new lab and office space. The area, located in South Lake Union, is part of a larger regional expansion of science facilities supported by major real estate developments and significant biotech investment.
Organizations
-
GeekWire Contributing Writer · current
